These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 24996516)
1. Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review. Gabriel L; Beriot-Mathiot A J Hosp Infect; 2014 Sep; 88(1):12-21. PubMed ID: 24996516 [TBL] [Abstract][Full Text] [Related]
2. Attributable Cost of Clostridium difficile Infection in Pediatric Patients. Mehrotra P; Jang J; Gidengil C; Sandora TJ Infect Control Hosp Epidemiol; 2017 Dec; 38(12):1472-1477. PubMed ID: 29173236 [TBL] [Abstract][Full Text] [Related]
3. Attributable costs and length of stay of hospital-acquired Leal JR; Conly J; Weaver R; Wick J; Henderson EA; Manns B; Ronksley P Infect Control Hosp Epidemiol; 2019 Oct; 40(10):1135-1143. PubMed ID: 31342884 [TBL] [Abstract][Full Text] [Related]
4. Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective. Leblanc S; Blein C; Andremont A; Bandinelli PA; Galvain T Infect Control Hosp Epidemiol; 2017 Aug; 38(8):906-911. PubMed ID: 28756805 [TBL] [Abstract][Full Text] [Related]
5. Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study. Tabak YP; Zilberberg MD; Johannes RS; Sun X; McDonald LC Infect Control Hosp Epidemiol; 2013 Jun; 34(6):588-96. PubMed ID: 23651889 [TBL] [Abstract][Full Text] [Related]
6. Burden of Clostridium (Clostridioides) difficile infection during inpatient stays in the USA between 2012 and 2016. Mollard S; Lurienne L; Heimann SM; Bandinelli PA J Hosp Infect; 2019 Jun; 102(2):135-140. PubMed ID: 30690052 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of fixed and variable hospital costs due to Clostridium difficile infection: institutional incentives and directions for future research. Ryan P; Skally M; Duffy F; Farrelly M; Gaughan L; Flood P; McFadden E; Fitzpatrick F J Hosp Infect; 2017 Apr; 95(4):415-420. PubMed ID: 28320542 [TBL] [Abstract][Full Text] [Related]
8. Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers. Pakyz A; Carroll NV; Harpe SE; Oinonen M; Polk RE Pharmacotherapy; 2011 Jun; 31(6):546-51. PubMed ID: 21923438 [TBL] [Abstract][Full Text] [Related]
9. The economic burden of Clostridium difficile. McGlone SM; Bailey RR; Zimmer SM; Popovich MJ; Tian Y; Ufberg P; Muder RR; Lee BY Clin Microbiol Infect; 2012 Mar; 18(3):282-9. PubMed ID: 21668576 [TBL] [Abstract][Full Text] [Related]
10. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study. Shah DN; Aitken SL; Barragan LF; Bozorgui S; Goddu S; Navarro ME; Xie Y; DuPont HL; Garey KW J Hosp Infect; 2016 Jul; 93(3):286-9. PubMed ID: 27209056 [TBL] [Abstract][Full Text] [Related]
11. The burden of Clostridium difficile in surgical patients in the United States. Zerey M; Paton BL; Lincourt AE; Gersin KS; Kercher KW; Heniford BT Surg Infect (Larchmt); 2007 Dec; 8(6):557-66. PubMed ID: 18171114 [TBL] [Abstract][Full Text] [Related]
12. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. Wiegand PN; Nathwani D; Wilcox MH; Stephens J; Shelbaya A; Haider S J Hosp Infect; 2012 May; 81(1):1-14. PubMed ID: 22498638 [TBL] [Abstract][Full Text] [Related]
13. Burden of Clostridium difficile infection: Associated hospitalization in a cohort of middle-aged and older adults. Chen Y; Glass K; Liu B; Korda RJ; Riley TV; Kirk MD Am J Infect Control; 2017 May; 45(5):508-511. PubMed ID: 28089675 [TBL] [Abstract][Full Text] [Related]
15. Trend, Risk Factors, and Costs of Clostridium difficile Infections in Vascular Surgery. Egorova NN; Siracuse JJ; McKinsey JF; Nowygrod R Ann Vasc Surg; 2015; 29(4):792-800. PubMed ID: 25595110 [TBL] [Abstract][Full Text] [Related]
16. Cost analysis of an outbreak of Clostridium difficile infection ribotype 027 in a Dutch tertiary care centre. van Beurden YH; Bomers MK; van der Werff SD; Pompe EAPM; Spiering S; Vandenbroucke-Grauls CMJE; Mulder CJJ J Hosp Infect; 2017 Apr; 95(4):421-425. PubMed ID: 28169013 [TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection. Rodrigues R; Barber GE; Ananthakrishnan AN Infect Control Hosp Epidemiol; 2017 Feb; 38(2):196-202. PubMed ID: 27817758 [TBL] [Abstract][Full Text] [Related]
18. The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting. Bond SE; Boutlis CS; Yeo WW; Pratt WAB; Orr ME; Miyakis S J Hosp Infect; 2017 Apr; 95(4):387-393. PubMed ID: 28131640 [TBL] [Abstract][Full Text] [Related]
19. Inpatient Expenditures Attributable to Hospital-Onset Clostridium difficile Infection: A Nationwide Case-Control Study in Japan. Fukuda H; Yano T; Shimono N Pharmacoeconomics; 2018 Nov; 36(11):1367-1376. PubMed ID: 30022364 [TBL] [Abstract][Full Text] [Related]
20. The prolongation of length of stay because of Clostridium difficile infection. Mitchell BG; Gardner A; Barnett AG; Hiller JE; Graves N Am J Infect Control; 2014 Feb; 42(2):164-7. PubMed ID: 24290226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]